Table 1. Baseline characteristics.
| Variable | Colchicine (n=15) | Placebo (n=12) |
|---|---|---|
| Age (years) | 50.2 ± 6.4 | 47.3 ± 6.2 |
| Sex (n, %) | ||
| Male | 3 (20%) | 2 (16.7%) |
| Female | 12 (80%) | 10 (83.3%) |
| Race (n, %) | ||
| White | 8 (53.3%) | 4 (33.3%) |
| Black | 3 (20%) | 3 (25%) |
| Multiracial/Unknown/Other | 4 (26.7%) | 5 (41.7%) |
| BMI (kg/m2) | 38.2 ± 3.1 | 39.5 ± 3.9 |
| Hemoglobin A1c (%) | 5.7 ± 0.2 | 5.4 ± 0.2 |
| hsCRP (mg/L) | 7.8 ± 4.1 | 6.5 ± 2.2 |
| GlycA (μmol/L) | 424.3 ± 27.5 | 420.4 ± 19.3 |
| IL-6 (rfu) | 677.3 ± 123.2 | 586.3 ± 32.2 |
| Resistin (rfu) | 4,350.7 ± 485.4 | 3,573.3 ± 486.0 |
| Neutrophils (K/uL) | 4.5 ± 0.8 | 3.3 ± 0.5 |
| WBC (K/uL) | 7.4 ± 1.0 | 6.0 ± 0.8 |
Baseline characteristics of randomized participants for whom stool samples for microbiome analysis were available. Values presented in mean ± SD format except where otherwise noted. BMI: body mass index; hsCRP: high-sensitivity C-reactive protein; GlycA: glycoprotein acetyls; IL-6: interleukin-6; rfu: relative fluorescence units; WBC: white blood cells.